← Back to headlines

Revolutionary Pancreatic Cancer Drug Shows Unprecedented Success
A new drug, daraxonrasib, targeting the KRAS oncogene, is showing unprecedented success in treating pancreatic cancer, according to experts.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



